{"content":"<li class=\"n-box-item date-title\" data-end=\"1381291199\" data-start=\"1381204800\" data-txt=\"Friday, December 20, 2019\">Tuesday, October  8, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1319602\" data-ts=\"1381271316\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYTR\" target=\"_blank\">CYTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1319602-cytrx-minus-6_5-percent-on-proposed-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CytRx -6.5% on proposed stock offering</a></h4><ul>     <li>CytRx (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CYTR\" title=\"CytRx Corporation\">CYTR</a>) <font color=\"red\">-6.5%</font> AH after announcing a public offering of common stock; the size of the offering is not disclosed.</li>     <li>CYTr says it intends to use the proceeds to fund clinical trials of its drug candidate aldoxorubicin and for general corporate purposes, which may include working capital, capital expenditures, R&amp;D and other commercial expenditures.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1319602\" data-linked=\"CytRx -6.5% on proposed stock offering\" data-tweet=\"$CYTR - CytRx -6.5% on proposed stock offering https://seekingalpha.com/news/1319602-cytrx-minus-6_5-percent-on-proposed-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/1319602-cytrx-minus-6_5-percent-on-proposed-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1319592\" data-ts=\"1381270803\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAS\" target=\"_blank\">CAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1319592-castle-minus-4-percent-ah-on-expectations-of-wider-q3-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Castle -4% AH on expectations of wider Q3 loss</a></h4><ul>     <li>A.M. Castle (NYSE:<a href=\"https://seekingalpha.com/symbol/CAS\" title=\"A. M. Castle &amp; Co.\">CAS</a>) expects a Q3 loss of $0.28-$0.32 vs. a -$0.11 consensus estimate and revenues of $250M-$255M vs. $277M consensus, due to continued weakness from key end markets.</li>     <li>CAS cites challenging industry conditions and overall softness in market selling prices as factors in lower sales and earnings levels for the quarter.</li>     <li>Shares <font color=\"red\">-4.1%</font> AH.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1319592\" data-linked=\"Castle -4% AH on expectations of wider Q3 loss\" data-tweet=\"$CAS - Castle -4% AH on expectations of wider Q3 loss https://seekingalpha.com/news/1319592-castle-minus-4-percent-ah-on-expectations-of-wider-q3-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/1319592-castle-minus-4-percent-ah-on-expectations-of-wider-q3-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1319542\" data-ts=\"1381268475\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APEN\" target=\"_blank\">APEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1319542-lpath-minus-10-percent-as-pfizer-may-divest-product-candidate-option\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lpath -10% as Pfizer may divest product candidate option</a></h4><ul>     <li>Lpath (LPTN) <font color=\"red\">-9.8%</font> AH after warning that Pfizer (NYSE:<a href=\"https://seekingalpha.com/symbol/PFE\" title=\"Pfizer Inc.\">PFE</a>) may divest its exclusive option to co-develop LPTN's leading product candidate, iSONEP.</li>     <li>In current Phase 2 clinical trials, iSONEP is given alone or in combination with other drugs to treat an ocular disease that often leads to blindness.</li>     <li>The original agreement with PFE included a $14M upfront payment and shared cost of the Phase 2 clinical trial; also, if PFE opted in after more data was obtained, future payments could be received by LPTN.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1319542\" data-linked=\"Lpath -10% as Pfizer may divest product candidate option\" data-tweet=\"$APEN $APEN $PFE - Lpath -10% as Pfizer may divest product candidate option https://seekingalpha.com/news/1319542-lpath-minus-10-percent-as-pfizer-may-divest-product-candidate-option?source=tweet\" data-url=\"https://seekingalpha.com/news/1319542-lpath-minus-10-percent-as-pfizer-may-divest-product-candidate-option\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1319522\" data-ts=\"1381268032\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1319522-after-hour-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-Hour Gainers / Losers</a></h4><ul><li><b>Top Gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/CALD' title='Callidus Software, Inc.'>CALD</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/MG' title='MISTRAS Group, Inc.'>MG</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/ATEC' title='Alphatec Holdings, Inc.'>ATEC</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/AMCN' title='AirMedia Group Inc'>AMCN</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/IWO' title='iShares Russell 2000 Growth ETF'>IWO</a> <font color='green'>+6%</font>.</li><li><b>Top Losers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/YUM' title='Yum! Brands, Inc.'>YUM</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/KNX' title='Knight-Swift Transportation Holdings Inc.'>KNX</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/JAZZ' title='Jazz Pharmaceuticals, Inc.'>JAZZ</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/FNGN' title='Financial Engines, Inc.'>FNGN</a> <font color='red'>-4%</font>. <a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a> <font color='red'>-4%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"1319522\" data-linked=\"After-Hour Gainers / Losers\" data-tweet=\"$CALD $MG $ATEC - After-Hour Gainers / Losers https://seekingalpha.com/news/1319522-after-hour-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1319522-after-hour-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1319512\" data-ts=\"1381267108\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KNX\" target=\"_blank\">KNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1319512-knight-transportation-lowers-eps-estimates-for-q3-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Knight Transportation lowers EPS estimates for Q3, Q4</a></h4><ul>     <li>Knight Transportation (NYSE:<a href=\"https://seekingalpha.com/symbol/KNX\" title=\"Knight-Swift Transportation Holdings Inc.\">KNX</a>) <font color=\"red\">-5.7%</font> AH after issuing downside earnings guidance for Q3 and Q4; it now sees Q3 EPS of $0.18-$0.20 vs. $0.22-$0.24 prior and $0.23 consensus estimate and Q4 EPS of $0.20-$0.23 vs. $0.22-$0.25 prior and $0.24 consensus.</li>     <li>KNX blames soft freight demand, challenges related to recruiting qualified driving associates, and new industry-wide regulations governing hours of service that went into effect in July for the disappointing Q3.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1319512\" data-linked=\"Knight Transportation lowers EPS estimates for Q3, Q4\" data-tweet=\"$KNX - Knight Transportation lowers EPS estimates for Q3, Q4 https://seekingalpha.com/news/1319512-knight-transportation-lowers-eps-estimates-for-q3-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/1319512-knight-transportation-lowers-eps-estimates-for-q3-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1319432\" data-ts=\"1381265000\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YUM\" target=\"_blank\">YUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1319432-yums-china-same-store-sales-to-drop-in-q4-eps-guidance-lowered\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yum&#39;s China same-store sales to drop in Q4; EPS guidance lowered</a></h4><ul>     <li>\n<a href=\"https://seekingalpha.com/symbol/YUM\" title=\"Yum! Brands, Inc.\">YUM</a>'s Chinese same-store sales fell 11% Y/Y in September (13% at KFC), slightly worse than <a href=\"https://seekingalpha.com/currents/post/1265782\" target=\"_blank\">August's 10%</a>. Moreover, the company now thinks it's \"unlikely China Division same-store sales will be positive for the fourth quarter.\"</li>     <li>Thanks to China and a higher-than-expected tax rate, Yum now expects 2013 EPS to be down by a \"high-single to low-double-digit percentage\" Y/Y; the consensus is for a 6% drop to $3.06. 2014 EPS growth of \"at least 20%\" is promised.</li>     <li>Same-store sales were flat in the U.S. and up 1% for Yum Restaurants International (YRI). Yum's global restaurant margin fell 1.3% Y/Y to 17.6%.</li>     <li>The China unit had a $335M op. profit -11% Y/Y. It added 132 restaurant units in Q3, raising its YTD total to 458. Sales +1% Y/Y.</li>     <li>YRI had a $163M op. profit, -6% Y/Y. 215 new units were added. Sales +1%. India division same-store sales were flat, but systems sales rose 24% thanks to unit growth.</li>     <li>The U.S. division had a $164M op. profit, +1% Y/Y. Growth would've been 6% if not for refranchising.</li>     <li>\n<a href=\"https://seekingalpha.com/symbol/YUM\" title=\"Yum! Brands, Inc.\">YUM</a> <font color=\"red\">-6.5%</font> AH. <a href=\"http://investors.yum.com/phoenix.zhtml?p=irol-eventDetails&amp;c=117941&amp;eventID=4937746\" target=\"_blank\">CC</a> at 9:15AM ET tomorrow. <a href=\"https://seekingalpha.com/currents/post/1319392\" target=\"_blank\">Q3 results</a>, PR.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1319432\" data-linked=\"Yum&#39;s China same-store sales to drop in Q4; EPS guidance lowered\" data-tweet=\"$YUM - Yum&#39;s China same-store sales to drop in Q4; EPS guidance lowered https://seekingalpha.com/news/1319432-yums-china-same-store-sales-to-drop-in-q4-eps-guidance-lowered?source=tweet\" data-url=\"https://seekingalpha.com/news/1319432-yums-china-same-store-sales-to-drop-in-q4-eps-guidance-lowered\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1319412\" data-ts=\"1381264694\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AA\" target=\"_blank\">AA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1319412-alcoa-posts-slight-profit-on-lower-costs-shares-plus-1_6-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alcoa posts slight profit on lower costs, shares +1.6% AH</a></h4><ul>     <li>Alcoa (NYSE:<a href=\"https://seekingalpha.com/symbol/AA\" title=\"Alcoa Corporation\">AA</a>) <font color=\"green\">+1.6%</font> AH following better than expected <a href=\"https://seekingalpha.com/currents/post/1319262\" target=\"_blank\">Q3 results</a> despite lower aluminum prices, helped by demand from auto makers and by cost-cutting moves.</li>\n<li>Operating income at AA's engineered products and solutions unit rose 22% to $192M, while the primary metals division reported a profit of $8M vs. a prior-year loss of $14M.</li>     <li>AA reaffirms its 2013 global aluminum demand growth forecast for 2013 and sees essentially balanced alumina and aluminum markets; it continues to project global growth this year across the aerospace (9%-10%), automotive (1%-4%), packaging (1%-2%), commercial building and  construction (4%-5%), and industrial gas turbine (3%-5%) end markets.</li>     <li>In the heavy truck and trailer market, AA raises its 2013 growth expectation to 5%-9% vs. 3%-8% earlier, on improvements in Europe and a stronger Chinese market.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1319412\" data-linked=\"Alcoa posts slight profit on lower costs, shares +1.6% AH\" data-tweet=\"$AA - Alcoa posts slight profit on lower costs, shares +1.6% AH https://seekingalpha.com/news/1319412-alcoa-posts-slight-profit-on-lower-costs-shares-plus-1_6-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1319412-alcoa-posts-slight-profit-on-lower-costs-shares-plus-1_6-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1319392\" data-ts=\"1381263827\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YUM\" target=\"_blank\">YUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1319392-yum-brands-misses-by-0_08-misses-on-revenues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YUM! Brands misses by $0.08, misses on revenues</a></h4><ul>\n<li>YUM! Brands (NYSE:<a href=\"https://seekingalpha.com/symbol/YUM\" title=\"Yum! Brands, Inc.\">YUM</a>): FQ3 EPS of $0.85 <font color=\"red\">misses by $0.08</font>.</li>\n<li>Revenue of $3.47B <font color=\"red\">misses by $0.06B</font>. Shares  <font color=\"red\">-5.8%</font> AH. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1319392\" data-linked=\"YUM! Brands misses by $0.08, misses on revenues\" data-tweet=\"$YUM - YUM! Brands misses by $0.08, misses on revenues https://seekingalpha.com/news/1319392-yum-brands-misses-by-0_08-misses-on-revenues?source=tweet\" data-url=\"https://seekingalpha.com/news/1319392-yum-brands-misses-by-0_08-misses-on-revenues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1319382\" data-ts=\"1381263665\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CALD\" target=\"_blank\">CALD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1319382-callidus-software-raises-guidance-shares-plus-9_1-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Callidus Software raises guidance, shares +9.1% AH</a></h4><ul>\n<li>Thanks to a strong Q3, Callidus (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CALD\" title=\"Callidus Software, Inc.\">CALD</a>) now expects 2013 revenue of $108.5M-$109.5M; that's favorable to a prior range of $106M-$109M and a $106.8M consensus. (PR)</li>\n<li>Q3 revenue is expected to be in a range of $28.5M-$29M, above prior guidance of $26M-$27M and a $26.6M consensus. SaaS (cloud-based) revenue is believed to have grown 22%-35% Y/Y, and SaaS billings 32%-35%.</li>\n<li>Full Q3 results are due on Oct. 31. <a href=\"https://seekingalpha.com/currents/post/1267692\" target=\"_blank\">Roth issued</a> a bullish note last month.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1319382\" data-linked=\"Callidus Software raises guidance, shares +9.1% AH\" data-tweet=\"$CALD - Callidus Software raises guidance, shares +9.1% AH https://seekingalpha.com/news/1319382-callidus-software-raises-guidance-shares-plus-9_1-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1319382-callidus-software-raises-guidance-shares-plus-9_1-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1319272\" data-ts=\"1381262692\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLUU\" target=\"_blank\">GLUU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1319272-glu-mobile-closes-higher-following-bullish-sa-column\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Glu Mobile closes higher following bullish SA column</a></h4><ul><li>SA contributor <a href=\"https://seekingalpha.com/article/1733512-the-light-at-the-end-of-glu-mobiles-tunnel-is-growing-brighter\" target=\"_blank\">Kelvin M.</a> highlights the strong performance of <em>Deer Hunter 2014&nbsp;</em>following its <a href=\"https://seekingalpha.com/currents/post/1289562\" target=\"_blank\">September launch</a>. Using the historical performance of <em>Zynga Poker</em> as a point of reference, the author thinks <em>Deer Hunter 2014</em> may have added $2.4M to Glu's (<a href='https://seekingalpha.com/symbol/GLUU' title='Glu Mobile Inc.'>GLUU</a> <font color='green'>+6.2%</font>) Q3 top line, and could boost Q4 sales by up to $20M.</li><li><em>Deer Hunter 2014 </em>is still ranked #1 on App Annie's <a href=\"http://www.appannie.com/top/\" target=\"_blank\">iPhone U.S. free download chart</a>, and #9 on its list of top-grossing apps. For <a href=\"http://www.appannie.com/top/ipad/united-states/\" target=\"_blank\">the iPad</a>, its rankings are #5 and #19, respective.</li><li><a href=\"https://seekingalpha.com/currents/post/1298502\" target=\"_blank\">Glu shot higher</a> two weeks ago after announcing strong initial download activity for <em>Deer Hunter 2014</em>.</li><li>Shares rallied today in spite of <a href=\"https://seekingalpha.com/currents/post/1318782\" target=\"_blank\">a general rout</a> in high-beta tech names.</li></ul><div class=\"tiny-share-widget\" data-id=\"1319272\" data-linked=\"Glu Mobile closes higher following bullish SA column\" data-tweet=\"$GLUU - Glu Mobile closes higher following bullish SA column https://seekingalpha.com/news/1319272-glu-mobile-closes-higher-following-bullish-sa-column?source=tweet\" data-url=\"https://seekingalpha.com/news/1319272-glu-mobile-closes-higher-following-bullish-sa-column\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1319262\" data-ts=\"1381262675\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AA\" target=\"_blank\">AA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1319262-alcoa-beats-by-0_05-beats-on-revenues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alcoa beats by $0.05, beats on revenues</a></h4><ul>\n<li>Alcoa (NYSE:<a href=\"https://seekingalpha.com/symbol/AA\" title=\"Alcoa Corporation\">AA</a>): FQ3 EPS of $0.11 <font color=\"green\">beats by $0.05</font>.</li>\n<li>Revenue of $5.8B <font color=\"green\">beats by $0.14B</font>. Shares  <font color=\"green\">+3.2%</font> AH. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1319262\" data-linked=\"Alcoa beats by $0.05, beats on revenues\" data-tweet=\"$AA - Alcoa beats by $0.05, beats on revenues https://seekingalpha.com/news/1319262-alcoa-beats-by-0_05-beats-on-revenues?source=tweet\" data-url=\"https://seekingalpha.com/news/1319262-alcoa-beats-by-0_05-beats-on-revenues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1319222\" data-ts=\"1381261757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARWR\" target=\"_blank\">ARWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1319222-arrowhead-plus-15-percent-on-funding-deal-initial-hepatitis-drug-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arrowhead +15% on funding deal, initial hepatitis drug data</a></h4><ul>     <li>Arrowhead Research (<a href=\"https://seekingalpha.com/symbol/ARWR\" title=\"Arrowhead Pharmaceuticals\">ARWR</a> <font color=\"green\">+15.2%</font>) jumps to 52-week highs after pricing a $60M private placement of stock at $5.86 - matching yesterday's closing price - clearing the way for the biotech company focused on genetic therapeutics to move ahead with another trial of its ARC-520 drug candidate to treat chronic hepatitis B virus infection.</li>     <li>ARWR also says it will move ahead with Phase IIa efficacy testing of ARC-520 after initial data from Phase I testing showed it was generally safe and well tolerated.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1319222\" data-linked=\"Arrowhead +15% on funding deal, initial hepatitis drug data\" data-tweet=\"$ARWR - Arrowhead +15% on funding deal, initial hepatitis drug data https://seekingalpha.com/news/1319222-arrowhead-plus-15-percent-on-funding-deal-initial-hepatitis-drug-data?source=tweet\" data-url=\"https://seekingalpha.com/news/1319222-arrowhead-plus-15-percent-on-funding-deal-initial-hepatitis-drug-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1319192\" data-ts=\"1381261015\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTR\" target=\"_blank\">NTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1319192-agrium-says-potash-prices-to-remain-pressured-amid-soap-opera\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agrium says potash prices to remain pressured amid &quot;soap opera&quot;</a></h4><ul>     <li>The Russian potash \"soap opera\" <a href=\"http://www.reuters.com/article/2013/10/08/agrium-potash-idUSL1N0HY0VK20131008\" target=\"_blank\">could weigh on prices</a> until demand rises substantially or producers shut some capacity, Agrium (AGU <font color=\"red\">-3.7%</font>) CEO Mike Wilson says at the fertilizer company's investor day.</li>     <li>The structure of the potash market has to go back to where it was before Russia's Uralkali quit its export partnership with Belaruskali, and some producers need to shut capacity, or demand has to soar above 60M metric tons, Wilson says; otherwise, prices will remain under pressure.</li>     <li>POT <font color=\"red\">-1.1%</font>, <a href=\"https://seekingalpha.com/symbol/MOS\" title=\"The Mosaic Company\">MOS</a> <font color=\"red\">-0.3%</font>, <a href=\"https://seekingalpha.com/symbol/CF\" title=\"CF Industries Holdings, Inc.\">CF</a> <font color=\"red\">-2.5%</font>, <a href=\"https://seekingalpha.com/symbol/IPI\" title=\"Intrepid Potash, Inc.\">IPI</a> <font color=\"red\">-3.4%</font>.</li>     <li>ETFs: <a href=\"https://seekingalpha.com/symbol/MOO\" title=\"VanEck Vectors Agribusiness ETF\">MOO</a>, <a href=\"https://seekingalpha.com/symbol/CROP\" title=\"IQ Global Agribusiness Small Cap ETF\">CROP</a>, <a href=\"https://seekingalpha.com/symbol/PAGG\" title=\"Invesco Global Agriculture Portfolio ETF\">PAGG</a>, <a href=\"https://seekingalpha.com/symbol/VEGI\" title=\"iShares MSCI Global Agricultural Producers ETF\">VEGI</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1319192\" data-linked=\"Agrium says potash prices to remain pressured amid &quot;soap opera&quot;\" data-tweet=\"$NTR $NTR $MOS - Agrium says potash prices to remain pressured amid &quot;soap opera&quot; https://seekingalpha.com/news/1319192-agrium-says-potash-prices-to-remain-pressured-amid-soap-opera?source=tweet\" data-url=\"https://seekingalpha.com/news/1319192-agrium-says-potash-prices-to-remain-pressured-amid-soap-opera\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1319122\" data-ts=\"1381259060\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNJ\" target=\"_blank\">JNJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1319122-jnj-buys-glaxo-hep-c-treatment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JNJ buys Glaxo hep C treatment</a></h4><ul>\n<li>Johnson &amp; Johnson's (<a href=\"https://seekingalpha.com/symbol/JNJ\" title=\"Johnson &amp; Johnson\">JNJ</a> <font color=\"red\">-0.7%</font>) purchase of GlaxoSmithKline's (<a href=\"https://seekingalpha.com/symbol/GSK\" title=\"GlaxoSmithKline\">GSK</a> <font color=\"red\">-1%</font>) hepatitis C treatment sends Idenix Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/IDIX\" title=\"Idenix Pharmaceuticals, Inc.\">IDIX</a> <font color=\"red\">-15.8%</font>) tumbling. JNJ <a href=\"http://www.bloomberg.com/news/2013-10-08/idenix-shares-fall-as-j-j-buys-rival-hepatitis-c-therapy.html?cmpid=yhoo\" target=\"_blank\">bought the rights</a> to a compound in a class of drugs called non-structural 5A protein inhibitors, suggesting it's close to ending its partnership with Identix based on its hep C therapies, including the NS5A drug samatasvir, says Wells' Brian Abrahams.</li>\n<li>\"Hep C battle lines (are) being drawn,\u201d says Abrahams. Idenix\u2019s drug \u201cwill need a new partner.\u201d</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1319122\" data-linked=\"JNJ buys Glaxo hep C treatment\" data-tweet=\"$JNJ $JNJ $GSK - JNJ buys Glaxo hep C treatment https://seekingalpha.com/news/1319122-jnj-buys-glaxo-hep-c-treatment?source=tweet\" data-url=\"https://seekingalpha.com/news/1319122-jnj-buys-glaxo-hep-c-treatment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1319102\" data-ts=\"1381258570\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/D\" target=\"_blank\">D</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1319102-cramer-likes-three-utilities-amid-debt-disaster\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cramer likes three utilities amid debt disaster</a></h4><ul>     <li>Jim Cramer touts three dividend yielding utilities as the <a href=\"http://www.cnbc.com/id/101092928\" target=\"_blank\">strongest bounceback candidates</a> in the event of a U.S. default.</li>     <li>Dominion's (<a href=\"https://seekingalpha.com/symbol/D\" title=\"Dominion Energy, Inc.\">D</a> <font color=\"green\">+0.2%</font>) strong core utility business allows for the continued increase in dividends, Cramer says, and an MLP spinoff will bring in lots of cash.</li>     <li>ConEdison (<a href=\"https://seekingalpha.com/symbol/ED\" title=\"Consolidated Edison Inc.\">ED</a> <font color=\"green\">+1.5%</font>) is a stock Cramer believes is somewhat insulated from the D.C. debacle simply because it services the New York metro area.</li>     <li>He likes Southern Company's (<a href=\"https://seekingalpha.com/symbol/SO\" title=\"Southern Company\">SO</a> <font color=\"green\">+1.4%</font>) \"long-term history of paying the dividend through the toughest times imaginable... they get the sanctity of the dividend better than just about any other utility.\"</li>     <li>Separately, New York Gov. Cuomo calls on the state's Public Service Commission to <a href=\"http://www.nydailynews.com/blogs/dailypolitics/2013/10/gov-cuomo-calls-on-public-service-commission-to-reject-proposed-con-ed-rate-hi\" target=\"_blank\">reject</a> ED\u2019s request for a rate hike next year.</li>     <li>Utilities are <a href=\"https://seekingalpha.com/currents/post/1318932\" target=\"_blank\">generally higher</a> today as investors avoid riskier bets amid shutdown and default nervousness.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1319102\" data-linked=\"Cramer likes three utilities amid debt disaster\" data-tweet=\"$D $D $ED - Cramer likes three utilities amid debt disaster https://seekingalpha.com/news/1319102-cramer-likes-three-utilities-amid-debt-disaster?source=tweet\" data-url=\"https://seekingalpha.com/news/1319102-cramer-likes-three-utilities-amid-debt-disaster\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1319092\" data-ts=\"1381258318\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1319092-stocks-move-to-new-lows-as-president-indicates-zero-progress\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks move to new lows as President indicates zero progress</a></h4><ul>\n<li>Stocks slip to new session lows as the President <a href=\"http://blogs.marketwatch.com/capitolreport/2013/10/08/obama-statement-on-shutdown-and-debt-ceiling-live-blog-and-video/\" target=\"_blank\">holds a news conference</a> on the shutdown and indicates zero progress towards ending the government shutdown and raising the debt ceiling.</li>\n<li>S&amp;P 500 (<a href=\"https://seekingalpha.com/symbol/spy\" title=\"SPDR S&amp;P 500 Trust ETF\">SPY</a> <font color=\"red\">-1%</font>), DJIA (<a href=\"https://seekingalpha.com/symbol/dia\" title=\"SPDR Dow Jones Industrial Average ETF\">DIA</a> <font color=\"red\">-0.8%</font>), Nasdaq 100 (<a href=\"https://seekingalpha.com/symbol/qqq\" title=\"PowerShares QQQ Trust ETF\">QQQ</a> <font color=\"red\">-1.8%</font>), Russell 2000 (<a href=\"https://seekingalpha.com/symbol/iwm\" title=\"iShares Russell 2000 ETF\">IWM</a> <font color=\"red\">-1.7%</font>).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1319092\" data-linked=\"Stocks move to new lows as President indicates zero progress\" data-tweet=\"$SPY $DIA $QQQ - Stocks move to new lows as President indicates zero progress https://seekingalpha.com/news/1319092-stocks-move-to-new-lows-as-president-indicates-zero-progress?source=tweet\" data-url=\"https://seekingalpha.com/news/1319092-stocks-move-to-new-lows-as-president-indicates-zero-progress\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318932\" data-ts=\"1381251869\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SO\" target=\"_blank\">SO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318932-utilities-well-bid-as-broader-market-slides\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Utilities well-bid as broader market slides</a></h4><ul>\n<li>Defense is working nicely today as the utility sector (<a href=\"https://seekingalpha.com/symbol/XLU\" title=\"Utilities Select Sector SPDR ETF\">XLU</a> <font color=\"green\">+1.4%</font>) makes a strong move higher with the rest of the market lit up bright red. Few have had use for the steady dividend payers since rates started rising in May, but the sector has stabilized over the past month and is particularly well-bid today amid panicky action in <a href=\"https://seekingalpha.com/currents/post/1318782\" target=\"_blank\">high-flying momentum favorites</a>.</li>\n<li>Some individual names: Southern Company (<a href=\"https://seekingalpha.com/symbol/SO\" title=\"Southern Company\">SO</a> <font color=\"green\">+1.9%</font>), Edison International (<a href=\"https://seekingalpha.com/symbol/EIX\" title=\"Edison International\">EIX</a> <font color=\"green\">+1.9%</font>), Duke Energy (<a href=\"https://seekingalpha.com/symbol/DUK\" title=\"Duke Energy Corporation\">DUK</a> <font color=\"green\">+1.6%</font>), FirstEnergy (<a href=\"https://seekingalpha.com/symbol/FE\" title=\"FirstEnergy Corp\">FE</a> <font color=\"green\">+1.5%</font>), XCel Energy (<a href=\"https://seekingalpha.com/symbol/XEL\" title=\"Xcel Energy Inc\">XEL</a> <font color=\"green\">+2.1%</font>), American Electric Power (<a href=\"https://seekingalpha.com/symbol/AEP\" title=\"American Electric Power Company Inc\">AEP</a> <font color=\"green\">+1.6%</font>).</li>\n<li>Related ETFs:Â <a href=\"https://seekingalpha.com/symbol/IDU\" title=\"iShares U.S. Utilities ETF\">IDU</a>, <a href=\"https://seekingalpha.com/symbol/PUI\" title=\"Invesco DWA Utilities Momentum Portfolio ETF\">PUI</a>, <a href=\"https://seekingalpha.com/symbol/XLU\" title=\"Utilities Select Sector SPDR ETF\">XLU</a>, <a href=\"https://seekingalpha.com/symbol/VPU\" title=\"Vanguard Utilities ETF\">VPU</a>, <a href=\"https://seekingalpha.com/symbol/RYU\" title=\"Invesco S&amp;P Equal Weight Utilities ETF\">RYU</a>, <a href=\"https://seekingalpha.com/symbol/FXU\" title=\"First Trust Utilities AlphaDEX ETF\">FXU</a>, <a href=\"https://seekingalpha.com/symbol/PSCU\" title=\"Invesco S&amp;P SmallCap Utilities Portfolio ETF\">PSCU</a>, <a href=\"https://seekingalpha.com/symbol/UPW\" title=\"ProShares Ultra Utilities ETF\">UPW</a>, <a href=\"https://seekingalpha.com/symbol/SDP\" title=\"ProShares UltraShort Utilities ETF\">SDP</a>, <a href=\"https://seekingalpha.com/symbol/UTLT\" title=\"Deutsche X-trackers Regulated Utilities ETF\">UTLT</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1318932\" data-linked=\"Utilities well-bid as broader market slides\" data-tweet=\"$SO $XLU $SO - Utilities well-bid as broader market slides https://seekingalpha.com/news/1318932-utilities-well-bid-as-broader-market-slides?source=tweet\" data-url=\"https://seekingalpha.com/news/1318932-utilities-well-bid-as-broader-market-slides\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318912\" data-ts=\"1381251490\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLNE\" target=\"_blank\">CLNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318912-clean-energy-sinks-after-piper-jaffray-labels-it-a-top-sell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clean Energy sinks after Piper Jaffray labels it a top sell</a></h4><ul>     <li>Clean Energy Fuels (<a href=\"https://seekingalpha.com/symbol/CLNE\" title=\"Clean Energy Fuels Corp.\">CLNE</a> <font color=\"red\">-8.5%</font>) is added to Piper Jaffray's <a href=\"http://www.streetinsider.com/Hot+Comments/Clean+Energy+Fuels+Corp.+%28CLNE%29+Added+to+Top+Picks+List+as+Sell+at+Piper/8758109.html\" target=\"_blank\">Top Picks List as a Sell</a> with a new $4.50 price target, cut from $9.50, saying trucking companies overwhelmingly prefer a type of natural gas CLNE doesn't sell.</li>     <li>The firm's channel checks indicate that more than 90% of engines emerging from the Cummins-Westport (<a href=\"https://seekingalpha.com/symbol/CMI\" title=\"Cummins Inc.\">CMI</a>; <a href=\"https://seekingalpha.com/symbol/WPRT\" title=\"Westport Fuel Systems, Inc.\">WPRT</a>) joint venture are opting for compressed natural gas, which fleets can obtain for $1.50/gallon, instead of liquefied natural gas, which CLNE sells for at least $2.75/gallon.</li>     <li>Also, the firm estimates CLNE will sell only 15M gallons of its Redeem fuel made from landfill gas next year; since CLNE will sell ~299M gallons of fuel in 2014, Redeem will not have a major impact on overall profit margins.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1318912\" data-linked=\"Clean Energy sinks after Piper Jaffray labels it a top sell\" data-tweet=\"$CLNE $CLNE $CMI - Clean Energy sinks after Piper Jaffray labels it a top sell https://seekingalpha.com/news/1318912-clean-energy-sinks-after-piper-jaffray-labels-it-a-top-sell?source=tweet\" data-url=\"https://seekingalpha.com/news/1318912-clean-energy-sinks-after-piper-jaffray-labels-it-a-top-sell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318892\" data-ts=\"1381250755\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318892-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Top 10 Gainers:</b> <a href='https://seekingalpha.com/symbol/VISN' title='VisionChina Media, Inc.'>VISN</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/ALTI' title='Altair Nanotechnologies Inc.'>ALTI</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/RCON' title='Recon Technology, Ltd.'>RCON</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/AMCN' title='AirMedia Group Inc'>AMCN</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/TISA' title='Top Image Systems, Ltd.'>TISA</a> <font color='green'>+14%</font>. ETRM <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/ARWR' title='Arrowhead Pharmaceuticals'>ARWR</a> <font color='green'>+10%</font>. HRT <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/AGEN' title='Agenus'>AGEN</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/NPD' title='China Nepstar Chain Drugstore Ltd.'>NPD</a> <font color='green'>+9%</font>.</li><li><b>Top 10 Losers:</b> <a href='https://seekingalpha.com/symbol/TWGP' title='Tower Group, Inc.'>TWGP</a> <font color='red'>-42%</font>. <a href='https://seekingalpha.com/symbol/CVM' title='Cel-Sci Corporation'>CVM</a> <font color='red'>-31%</font>. ADHD <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/IDIX' title='Idenix Pharmaceuticals, Inc.'>IDIX</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/GERN' title='Geron Corporation'>GERN</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/JMBA' title='Jamba, Inc.'>JMBA</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a> <font color='red'>-16%</font>.&nbsp; <a href='https://seekingalpha.com/symbol/JRJC' title='China Finance Online Co. Limited'>JRJC</a> <font color='red'>-17%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1318892\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$VISN $ALTI $RCON - Midday Gainers / Losers https://seekingalpha.com/news/1318892-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1318892-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318872\" data-ts=\"1381250272\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SA\" target=\"_blank\">SA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318872-seabridge-gold-moving-deep-kerr-towards-high-grade-resource\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seabridge Gold moving Deep Kerr towards high-grade resource</a></h4><ul>     <li>Seabridge Gold (<a href='https://seekingalpha.com/symbol/SA' title='Seabridge Gold Inc'>SA</a> <font color='green'>+2.6%</font>) says it has received additional <a href=\"http://finance.yahoo.com/news/seabridge-gold-moving-deep-kerr-120000921.html\" target=\"_blank\">\"exceptional\" drill results from the Deep Kerr core zone</a>, confirming the likelihood of being able to calculate a sizable resource estimate for the new discovery after just one season of drilling.</li>     <li>Of 29 holes drilled at Deep Kerr this summer, 26 have hit the high-grade zone; assays have been received for 15 of the 26 holes, and all 15 have intersected wide intervals grading at or above 0.5% copper and  13 have major intercepts averaging above 0.6% copper.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1318872\" data-linked=\"Seabridge Gold moving Deep Kerr towards high-grade resource\" data-tweet=\"$SA - Seabridge Gold moving Deep Kerr towards high-grade resource https://seekingalpha.com/news/1318872-seabridge-gold-moving-deep-kerr-towards-high-grade-resource?source=tweet\" data-url=\"https://seekingalpha.com/news/1318872-seabridge-gold-moving-deep-kerr-towards-high-grade-resource\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318842\" data-ts=\"1381249616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RSLS\" target=\"_blank\">RSLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318842-enteromedics-skyrockets-after-canaccord-doubles-target-price\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EnteroMedics skyrockets after Canaccord doubles target price</a></h4><ul>     <li>EnteroMedics (ETRM <font color=\"green\">+12.8%</font>) is reiterated with a Buy rating but a new $3 price target (up from $1.50) at Canaccord Genuity, implying a <a href=\"http://247wallst.com/healthcare-business/2013/10/08/analysts-target-150-upside-in-enteromedics-stock-price/\" target=\"_blank\">potential 150% upside</a> for the stock.</li>     <li>The firm believes the risk/reward is favorable for investors with a speculative risk profile, seeing a high likelihood of a positive FDA panel result in Q4 2013 or Q1 2014 for ETRM's Maestro System for obesity given the relative safety of the device, moderate weight loss, and lack of alternatives for obese patients.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1318842\" data-linked=\"EnteroMedics skyrockets after Canaccord doubles target price\" data-tweet=\"$RSLS - EnteroMedics skyrockets after Canaccord doubles target price https://seekingalpha.com/news/1318842-enteromedics-skyrockets-after-canaccord-doubles-target-price?source=tweet\" data-url=\"https://seekingalpha.com/news/1318842-enteromedics-skyrockets-after-canaccord-doubles-target-price\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318782\" data-ts=\"1381247335\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318782-risk-off-high-flying-u-s-chinese-internet-stocks-get-hammered\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Risk off? High-flying U.S., Chinese Internet stocks get hammered</a></h4><ul>     <li>With the government shutdown having reached day 8, many U.S. and Chinese Internet stocks that have seen giant 2013 gains (often with the help of momentum traders and/or <a href=\"https://seekingalpha.com/currents/post/1190972\" target=\"_blank\">short squeezes</a>) are falling sharply.</li>     <li>U.S. decliners include Facebook (<a href=\"https://seekingalpha.com/symbol/FB\" title=\"Facebook\">FB</a> <font color=\"red\">-5.2%</font>), Yahoo (YHOO <font color=\"red\">-5.2%</font>), Netflix (<a href=\"https://seekingalpha.com/symbol/NFLX\" title=\"Netflix, Inc.\">NFLX</a> <font color=\"red\">-4.7%</font>), LinkedIn (LNKD <font color=\"red\">-7%</font>), Zillow (<a href=\"https://seekingalpha.com/symbol/Z\" title=\"Zillow Group, Inc.\">Z</a> <font color=\"red\">-5.3%</font>), Trulia (TRLA <font color=\"red\">-7.5%</font>), Yelp (<a href=\"https://seekingalpha.com/symbol/YELP\" title=\"Yelp\">YELP</a> <font color=\"red\">-9.3%</font>), Groupon (<a href=\"https://seekingalpha.com/symbol/GRPN\" title=\"Groupon, Inc.\">GRPN</a> <font color=\"red\">-4.9%</font>), and Web.com (WWWW <font color=\"red\">-10.2%</font>).</li>     <li>Chinese decliners include Baidu (<a href=\"https://seekingalpha.com/symbol/BIDU\" title=\"Baidu, Inc.\">BIDU</a> <font color=\"red\">-6.2%</font>), Sina (<a href=\"https://seekingalpha.com/symbol/SINA\" title=\"Sina Corporation\">SINA</a> <font color=\"red\">-7.5%</font>), YY (<a href=\"https://seekingalpha.com/symbol/YY\" title=\"YY Inc.\">YY</a> <font color=\"red\">-7.3%</font>), Sohu (<a href=\"https://seekingalpha.com/symbol/SOHU\" title=\"Sohu.com Inc.\">SOHU</a> <font color=\"red\">-5.1%</font>), Renren (<a href=\"https://seekingalpha.com/symbol/RENN\" title=\"Renren Inc.\">RENN</a> <font color=\"red\">-9.2%</font>), Youku (<a href=\"https://seekingalpha.com/symbol/YOKU\" title=\"Youku Tudou Inc.\">YOKU</a> <font color=\"red\">-9.6%</font>), Vipshop (<a href=\"https://seekingalpha.com/symbol/VIPS\" title=\"Vipshop Holdings\">VIPS</a> <font color=\"red\">-6.9%</font>), and Dangdang (<a href=\"https://seekingalpha.com/symbol/DANG\" title=\"E-Commerce China Dangdang Inc.\">DANG</a> <font color=\"red\">-10.7%</font>).</li>     <li>\n<a href=\"http://ycharts.com/companies/FB/chart/#/?series=type:company,id:FB,calc:price,,type:company,id:YHOO,calc:price,,type:company,id:NFLX,calc:price,,type:company,id:LNKD,calc:price,,type:company,id:GRPN,calc:price,,id:BIDU,type:company,calc:price,,id:SINA,type:company,calc:price,,id:Z,type:company,calc:price,,id:TRLA,type:company,calc:price,,id:YOKU,type:company,calc:price,,id:WWWW,type:company,calc:price,,id:YELP,type:company,calc:price&amp;zoom=ytd&amp;startDate=&amp;endDate=&amp;format=indexed&amp;recessions=false&amp;chartView=\" target=\"_blank\">A chart</a> of the YTD performance of some key names speaks for itself.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1318782\" data-linked=\"Risk off? High-flying U.S., Chinese Internet stocks get hammered\" data-tweet=\"$FB $FB $AABA - Risk off? High-flying U.S., Chinese Internet stocks get hammered https://seekingalpha.com/news/1318782-risk-off-high-flying-u-s-chinese-internet-stocks-get-hammered?source=tweet\" data-url=\"https://seekingalpha.com/news/1318782-risk-off-high-flying-u-s-chinese-internet-stocks-get-hammered\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318662\" data-ts=\"1381244306\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACAD\" target=\"_blank\">ACAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318662-acadia-pharma-minus-18-percent-on-rumor-but-no-hard-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acadia Pharma -18% on rumor but no hard news</a></h4><ul>     <li>Acadia Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a> <font color='red'>-17.9%</font>) shares are down sharply, with no recent news or information to account for the move, though biotech blogger Adam Feuerstein tweets a rumor that  today's decline is due to a doctor on a Cowen panel having a <a href=\"https://twitter.com/adamfeuerstein/status/387580906661089280\" target=\"_blank\">bearish  stance</a> on its lead drug candidate <a href=\"https://seekingalpha.com/currents/search?query=acadia+pimavanserin\" target=\"_blank\">pimavanserin</a>.</li>     <li>Pimavanserin is in Phase 3 development as a potential first-in-class treatment for Parkinson's disease psychosis, and ACAD established an expedited path to an NDA filing in Q2.</li>     <li>Shares are up 403% YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1318662\" data-linked=\"Acadia Pharma -18% on rumor but no hard news\" data-tweet=\"$ACAD - Acadia Pharma -18% on rumor but no hard news https://seekingalpha.com/news/1318662-acadia-pharma-minus-18-percent-on-rumor-but-no-hard-news?source=tweet\" data-url=\"https://seekingalpha.com/news/1318662-acadia-pharma-minus-18-percent-on-rumor-but-no-hard-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318632\" data-ts=\"1381243387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIO\" target=\"_blank\">FIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318632-fusion-io-jumps-again-due-to-m-and-a-speculation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fusion-io jumps (again) due to M&amp;A speculation</a></h4><ul><li>Fusion-io (<a href='https://seekingalpha.com/symbol/FIO' title='Fusion-io, Inc.'>FIO</a> <font color='green'>+4.7%</font>), which <a href=\"https://seekingalpha.com/currents/post/1269072\" target=\"_blank\">skyrocketed</a> last month after the <a href=\"https://seekingalpha.com/currents/post/1267432\" target=\"_blank\">Western Digital/Virident deal</a> stoked acquisition hopes, is jumping again due to M&amp;A rumors.</li><li>This is a good time to remember 23.4% of Fusion-io's float was shorted as of Sep. 13.</li></ul><div class=\"tiny-share-widget\" data-id=\"1318632\" data-linked=\"Fusion-io jumps (again) due to M&amp;A speculation\" data-tweet=\"$FIO - Fusion-io jumps (again) due to M&amp;A speculation https://seekingalpha.com/news/1318632-fusion-io-jumps-again-due-to-m-and-a-speculation?source=tweet\" data-url=\"https://seekingalpha.com/news/1318632-fusion-io-jumps-again-due-to-m-and-a-speculation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318622\" data-ts=\"1381243069\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLD\" target=\"_blank\">CLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318622-cloud-peak-energy-plus-2_2-percent-after-stifel-raises-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cloud Peak Energy +2.2% after Stifel raises to Buy</a></h4><ul>     <li>Cloud Peak Energy (<a href=\"https://seekingalpha.com/symbol/CLD\" title=\"Cloud Peak Energy, Inc.\">CLD</a> <font color=\"green\">+2.2%</font>) is <a href=\"http://www.streetinsider.com/Upgrades/Stifel+Nicolaus+Upgrades+Cloud+Peak+Energy+%28CLD%29+to+Buy/8758061.html\" target=\"_blank\">upgraded to Buy</a> from Hold with an $18 target price at Stifel Nicolaus.</li>     <li>Valuation is compelling, in Stifel's view, at an EV/EBITDA  multiple of 5.3x its unchanged 2014 EBITDA estimate of $227M vs. the U.S. coal mining peer group average of 7.9x.</li>     <li>A Q3 volume recovery in CLD's home turf of the Powder River Basin probably helps the near-term earnings outlook, although the firm is more encouraged by industry moves to cut capacity in an ongoing soft market for U.S. thermal coal.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1318622\" data-linked=\"Cloud Peak Energy +2.2% after Stifel raises to Buy\" data-tweet=\"$CLD $CLDPQ - Cloud Peak Energy +2.2% after Stifel raises to Buy https://seekingalpha.com/news/1318622-cloud-peak-energy-plus-2_2-percent-after-stifel-raises-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/1318622-cloud-peak-energy-plus-2_2-percent-after-stifel-raises-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318592\" data-ts=\"1381242510\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318592-itunes-radio-reportedly-set-to-launch-overseas\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">iTunes Radio reportedly set to launch overseas</a></h4><ul><li><a href=\"http://www.bloomberg.com/news/2013-10-07/apple-said-to-expand-itunes-radio-to-u-k-before-pandora.html\" target=\"_blank\">Bloomberg reports</a> Apple (<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a> <font color='green'>+0.4%</font>) plans to bring iTunes Radio to other English-speaking countries (the U.K., Canada, Australia, New Zealand), as well as to Nordic markets, by early 2014. The report comes after iTunes/Internet services chief Eddy Cue remarked Apple wants to eventually bring iTunes Radio to 100+ countries.</li><li>Pandora (<a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a> <font color='red'>-2.6%</font>) only offers services in the U.S., Australia, and New Zealand, markets where it can at least partly rely on royalty terms set by government agencies. Apple, which has directly negotiated with studios, doesn't have such limitations. But while the company won't have to deal with Pandora in Europe (for now, anyway), it will have to contend with <a href=\"https://seekingalpha.com/currents/post/1266092\" target=\"_blank\">fast-growing </a>Spotify.</li><li>Pandora sold off two weeks ago after Apple announced iTunes Radio had reeled in <a href=\"https://seekingalpha.com/currents/post/1293612\" target=\"_blank\">11M unique listeners</a> less than a week after it launched. But shares later rebounded, and were close to their 52-week high going into today.</li></ul><div class=\"tiny-share-widget\" data-id=\"1318592\" data-linked=\"iTunes Radio reportedly set to launch overseas\" data-tweet=\"$AAPL $AAPL $P - iTunes Radio reportedly set to launch overseas https://seekingalpha.com/news/1318592-itunes-radio-reportedly-set-to-launch-overseas?source=tweet\" data-url=\"https://seekingalpha.com/news/1318592-itunes-radio-reportedly-set-to-launch-overseas\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318562\" data-ts=\"1381241534\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCZ\" target=\"_blank\">OCZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318562-ocz-finally-releases-fq1-results-fq2-10-q-mistakenly-filed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OCZ finally releases FQ1 results, FQ2 10-Q mistakenly filed</a></h4><ul>\n<li>OCZ (<a href=\"https://seekingalpha.com/symbol/OCZ\" title=\"OCZ Technology Group Inc\">OCZ</a> <font color=\"red\">-7.1%</font>), which has been dealing with an accounting review for a year, has finally released its FQ1 (May quarter) results. The company has also filed 10-Qs (<a href=\"http://www.sec.gov/Archives/edgar/data/1355128/000119312513393190/d451980d10q.htm\" target=\"_blank\">I</a>, <a href=\"http://www.sec.gov/Archives/edgar/data/1355128/000119312513393187/d597935d10q.htm\" target=\"_blank\">II</a>) for FQ1 and FQ2, and a <a href=\"http://www.sec.gov/Archives/edgar/data/1355128/000119312513393189/d560743d10k.htm\" target=\"_blank\">10-K</a> for FY13 (ended Feb. '13). However, OCZ says its FQ2 10-Q was mistakenly filed by its financial printer (shades of <a href=\"https://seekingalpha.com/currents/post/594741\" target=\"_blank\">Google and R.R. Donnelley</a>), and shouldn't be relied upon.</li>\n<li>OCZ had FQ1 revenue of $55.3M (-28% Y/Y), and EPS of -$0.14 (better than -$0.44 a year earlier). Thanks to a mix shift towards enterprise sales and an FQ4 inventory write-down, gross margin was 15.5%, up from 2.4% in FQ4 and -10.7% a year earlier. Opex -14% Y/Y to $19.7M.</li>\n<li>U.S. sales rose 32% Y/Y, but international sales fell 53%.</li>\n<li>The mistakenly-filed 10-Q indicates OCZ had FQ2 revenue of $32.9M (-63% Y/Y), and GAAP EPS of -$0.30. GAAP gross margin was reportedly a mere 3.1%, and free cash flow -$23.3M. Cash/equivalents are said to be at $10.6M at quarter's end.</li>\n<li>OCZ says it \"faced significant challenges securing flash\" in the first half of FY14, and thinks flash availability/pricing was affected by the company's credit situation. This, in turn, impacted FQ2 gross margin. Also, a customer's completion of a data center project is said to have hurt sales.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1318562\" data-linked=\"OCZ finally releases FQ1 results, FQ2 10-Q mistakenly filed\" data-tweet=\"$OCZ - OCZ finally releases FQ1 results, FQ2 10-Q mistakenly filed https://seekingalpha.com/news/1318562-ocz-finally-releases-fq1-results-fq2-10-q-mistakenly-filed?source=tweet\" data-url=\"https://seekingalpha.com/news/1318562-ocz-finally-releases-fq1-results-fq2-10-q-mistakenly-filed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318532\" data-ts=\"1381240989\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAXN\" target=\"_blank\">AAXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318532-taser-gains-as-price-cut-put-in-context\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Taser gains as price cut put in context</a></h4><ul>\n<li>The Taser (TASR <font color=\"green\">+5.5%</font>) price cut is <a href=\"http://blogs.barrons.com/stockstowatchtoday/2013/10/08/taser-gains-2-as-price-cut-not-all-it-seems/?mod=BOL_hpp_blog_stw\" target=\"_blank\">not as bad as it seems</a>, says JPMorgan's Paul Coster, who took the time to listen on the company conference call.</li>\n<li>It's more a debundling of its Axon/Evidence.com service as total solution pricing has not changed - the company now charges for the first year of evidence.com storage and license fees. The new strategy is intended to eliminate customized sales contracts, thus accelerating the sales cycle.</li>\n<li>Coster ups his price target to $13 from $12, but keeps the stock rated a Hold.</li>\n<li>Related: <a href=\"https://seekingalpha.com/symbol/RGR\" title=\"Sturm, Ruger &amp; Company Inc.\">RGR</a>Â <font color=\"green\">+1.4%</font>, SWHCÂ <font color=\"green\">+1.1%</font>.</li>\n<li>Previous: The<a href=\"https://seekingalpha.com/currents/post/1312932\" target=\"_blank\"> price cut story</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1318532\" data-linked=\"Taser gains as price cut put in context\" data-tweet=\"$AAXN $AAXN $RGR - Taser gains as price cut put in context https://seekingalpha.com/news/1318532-taser-gains-as-price-cut-put-in-context?source=tweet\" data-url=\"https://seekingalpha.com/news/1318532-taser-gains-as-price-cut-put-in-context\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318492\" data-ts=\"1381239914\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNSR\" target=\"_blank\">FNSR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318492-a-roundup-of-tech-ratings-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A roundup of tech ratings changes</a></h4><ul><li>Finisar (<a href='https://seekingalpha.com/symbol/FNSR' title='Finisar Corporation'>FNSR</a> <font color='green'>+4.6%</font>) has been upgraded to Hold by Jefferies.</li><li>Audience (<a href='https://seekingalpha.com/symbol/ADNC' title='Audience, Inc'>ADNC</a> <font color='green'>+5.3%</font>) has been upgraded to Buy by Chardan Capital</li><li>AudioCodes (<a href='https://seekingalpha.com/symbol/AUDC' title='AudioCodes Ltd.'>AUDC</a> <font color='red'>-2.7%</font>) and Ceva (<a href='https://seekingalpha.com/symbol/CEVA' title='CEVA, Inc.'>CEVA</a> <font color='red'>-2%</font>) have been cut to Market Perform by Oppenheimer.</li><li>Canadian Solar (<a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a> <font color='green'>+2.6%</font>) has been started at Outperform by Northland Securities.</li></ul><div class=\"tiny-share-widget\" data-id=\"1318492\" data-linked=\"A roundup of tech ratings changes\" data-tweet=\"$FNSR $FNSR $ADNC - A roundup of tech ratings changes https://seekingalpha.com/news/1318492-a-roundup-of-tech-ratings-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/1318492-a-roundup-of-tech-ratings-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318472\" data-ts=\"1381239435\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSW\" target=\"_blank\">SSW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318472-seaspan-lower-after-issuing-new-stock-and-notes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seaspan lower after issuing new stock and notes</a></h4><ul> <li>Seaspan (<a href='https://seekingalpha.com/symbol/SSW' title='Seaspan Corporation'>SSW</a> <font color='red'>-6%</font>) slumps after the company <a href=\"https://seekingalpha.com/currents/post/1317422?source=feed_f\" target=\"_blank\">announces</a> a public offering of common stock and notes.</li> <li>In early trading, shares of Seaspan are at a multi-week low.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1318472\" data-linked=\"Seaspan lower after issuing new stock and notes\" data-tweet=\"$SSW - Seaspan lower after issuing new stock and notes https://seekingalpha.com/news/1318472-seaspan-lower-after-issuing-new-stock-and-notes?source=tweet\" data-url=\"https://seekingalpha.com/news/1318472-seaspan-lower-after-issuing-new-stock-and-notes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318372\" data-ts=\"1381237791\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318372-premarket-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers</a></h4><ul>\n<li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/AGEN\" title=\"Agenus\">AGEN</a> <font color=\"green\">+19%</font>. <a href=\"https://seekingalpha.com/symbol/CBMX\" title=\"CombiMatrix Corporation\">CBMX</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/NAVB\" title=\"Navidea Biopharmaceuticals\">NAVB</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/CPRX\" title=\"Catalyst Pharmaceuticals, Inc.\">CPRX</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/TLM\" title=\"Talisman Energy Inc.\">TLM</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/JCP\" title=\"J.C. Penney Company Inc.\">JCP</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/SOL\" title=\"ReneSola Ltd.\">SOL</a> <font color=\"green\">+5%</font>. <a href=\"https://seekingalpha.com/symbol/ANV\" title=\"Allied Nevada Gold Corp\">ANV</a> <font color=\"green\">+6%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/TWGP\" title=\"Tower Group, Inc.\">TWGP</a> <font color=\"red\">-29%</font>. <a href=\"https://seekingalpha.com/symbol/CVM\" title=\"Cel-Sci Corporation\">CVM</a> <font color=\"red\">-25%</font>. <a href=\"https://seekingalpha.com/symbol/JMBA\" title=\"Jamba, Inc.\">JMBA</a> <font color=\"red\">-18%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1318372\" data-linked=\"Premarket Gainers / Losers\" data-tweet=\"$AGEN $CBMX $NAVB - Premarket Gainers / Losers https://seekingalpha.com/news/1318372-premarket-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1318372-premarket-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318352\" data-ts=\"1381237573\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KERX\" target=\"_blank\">KERX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318352-keryx-plus-3-percent-after-zerenex-nda-filing-accepted-by-fda\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Keryx +3% after Zerenex NDA filing accepted by FDA</a></h4><ul>     <li>Keryx Biopharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/KERX\" title=\"Keryx Biopharmaceuticals, Inc.\">KERX</a>) <font color=\"green\">+3.1%</font> premarket after announcing its New Drug Application for Zerenex has been accepted for filing by the FDA.</li>     <li>The NDA seeks approval for the marketing and sale of Zerenex as a treatment for elevated serum phosphorus levels in patients with chronic kidney disease on dialysis.</li>     <li>Included in the NDA filing are safety and efficacy datasets derived from Phase 3 registration, as well as data from several additional studies, including four Phase 3 studies conducted in Japan in CKD patients on dialysis.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1318352\" data-linked=\"Keryx +3% after Zerenex NDA filing accepted by FDA\" data-tweet=\"$KERX - Keryx +3% after Zerenex NDA filing accepted by FDA https://seekingalpha.com/news/1318352-keryx-plus-3-percent-after-zerenex-nda-filing-accepted-by-fda?source=tweet\" data-url=\"https://seekingalpha.com/news/1318352-keryx-plus-3-percent-after-zerenex-nda-filing-accepted-by-fda\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318282\" data-ts=\"1381236633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNW\" target=\"_blank\">GNW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318282-btig-makes-genworth-a-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BTIG makes Genworth a Buy</a></h4><ul>\n<li>Genworth Financial (NYSE:<a href=\"https://seekingalpha.com/symbol/GNW\" title=\"Genworth Financial, Inc.\">GNW</a>) Is <a href=\"http://www.streetinsider.com/Upgrades/BTIG+Upgrades+Genworth+Financial+%28GNW%29+to+Buy/8758713.html\" target=\"_blank\">upgraded to Buy</a> with $17.50 price target at BTIG.</li>\n<li>SharesÂ <font color=\"green\">+3.4%</font>Â premarket to $13.09.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1318282\" data-linked=\"BTIG makes Genworth a Buy\" data-tweet=\"$GNW - BTIG makes Genworth a Buy https://seekingalpha.com/news/1318282-btig-makes-genworth-a-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/1318282-btig-makes-genworth-a-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318222\" data-ts=\"1381235277\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGEN\" target=\"_blank\">AGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318222-agenus-says-gsks-vaccine-candidate-reduces-malaria-infection\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agenus says GSK&#39;s vaccine candidate reduces malaria infection</a></h4><ul>     <li>Agenus (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AGEN\" title=\"Agenus\">AGEN</a>) <font color=\"green\">+9%</font> premarket after announcing that GlaxoSmithKline's (NYSE:<a href=\"https://seekingalpha.com/symbol/GSK\" title=\"GlaxoSmithKline\">GSK</a>) RTS,S malaria vaccine candidate, which contains Agenus' QS-21 Stimulon1 adjuvant, reduced malaria infection in young children and infants up to 18 months post vaccination, according to new Phase 3 data.</li>     <li>According to the results, children aged 5-17 months at first vaccination  with RTS,S experienced 46% fewer cases of clinical malaria, vs. children immunized with a control vaccine.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1318222\" data-linked=\"Agenus says GSK&#39;s vaccine candidate reduces malaria infection\" data-tweet=\"$AGEN $AGEN $GSK - Agenus says GSK&#39;s vaccine candidate reduces malaria infection https://seekingalpha.com/news/1318222-agenus-says-gsks-vaccine-candidate-reduces-malaria-infection?source=tweet\" data-url=\"https://seekingalpha.com/news/1318222-agenus-says-gsks-vaccine-candidate-reduces-malaria-infection\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318192\" data-ts=\"1381235030\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JMBA\" target=\"_blank\">JMBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318192-jamba-sinks-after-guidance-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jamba sinks after guidance cut</a></h4><ul> <li>Northland Capital cuts its rating on Jamba (NASDAQ:<a href=\"https://seekingalpha.com/symbol/JMBA\" title=\"Jamba, Inc.\">JMBA</a>) to Market Perform after the company issued <a href=\"https://seekingalpha.com/currents/post/1317522\" target=\"_blank\">disappointing guidance</a>.</li> <li>Analysts think the breakdown in sales is tied to more than just a widespread slowdown in consumer spending and weather issues.</li>  <li>JMBA <font color=\"red\">-14.9%</font> premarket to $11.46.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1318192\" data-linked=\"Jamba sinks after guidance cut\" data-tweet=\"$JMBA - Jamba sinks after guidance cut https://seekingalpha.com/news/1318192-jamba-sinks-after-guidance-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/1318192-jamba-sinks-after-guidance-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318102\" data-ts=\"1381233379\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAVB\" target=\"_blank\">NAVB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318102-navidea-biopharma-plus-7_4-percent-on-final-results-of-lymphoseek-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Navidea BioPharma +7.4% on final results of Lymphoseek study</a></h4><ul>     <li>Navidea BioPharma (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/NAVB\" title=\"Navidea Biopharmaceuticals\">NAVB</a>) <font color=\"green\">+7.4%</font> premarket following release of Phase 3 clinical trial data for its Lymphoseek injection in patients with head and neck squamous cell carcinoma.</li>     <li>The now-completed full study indicates Lymphoseek met all pre-specified study endpoints, including sensitivity, negative predictive value and overall accuracy relative to the pathology status of non-SLNs.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1318102\" data-linked=\"Navidea BioPharma +7.4% on final results of Lymphoseek study\" data-tweet=\"$NAVB - Navidea BioPharma +7.4% on final results of Lymphoseek study https://seekingalpha.com/news/1318102-navidea-biopharma-plus-7_4-percent-on-final-results-of-lymphoseek-study?source=tweet\" data-url=\"https://seekingalpha.com/news/1318102-navidea-biopharma-plus-7_4-percent-on-final-results-of-lymphoseek-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318052\" data-ts=\"1381232616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCPIQ\" target=\"_blank\">MCPIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318052-molycorp-names-bedford-as-next-president-ceo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Molycorp names Bedford as next President/CEO</a></h4><ul>     <li>Molycorp (MCP) names Geoff Bedford as its <a href=\"http://finance.yahoo.com/news/molycorp-names-industry-veteran-geoff-113701113.html\" target=\"_blank\">next President and CEO</a>, effective Dec. 2; he will replace interim President/CEO Constantine Karayannopoulos, who will continue as vice chairman of the MCP board.</li>     <li>Bedford is MCP's current Chief Operating Officer and a 14-year rare earth industry veteran.</li>\n<li>Separately, MCP amends a <a href=\"http://biz.yahoo.com/e/131007/mcp8-k.html\" target=\"_blank\">securities purchase agreement</a>, allowing Molymet to own up to 27.5% of MCP outstanding common stock.</li>     <li>Shares <font color=\"green\">+2.8%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1318052\" data-linked=\"Molycorp names Bedford as next President/CEO\" data-tweet=\"$MCPIQ - Molycorp names Bedford as next President/CEO https://seekingalpha.com/news/1318052-molycorp-names-bedford-as-next-president-ceo?source=tweet\" data-url=\"https://seekingalpha.com/news/1318052-molycorp-names-bedford-as-next-president-ceo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318042\" data-ts=\"1381232409\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318042-j-c-penney-higher-after-issuing-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.C. Penney higher after issuing update</a></h4><ul> <li>J.C. Penney (NYSE:<a href=\"https://seekingalpha.com/symbol/JCP\" title=\"J.C. Penney Company Inc.\">JCP</a>) reports comparable store sales fell 4% in September to show an improving trend. Online sales finally showed some strength.</li> <li>The retailer warns that margins continue to be impacted by the clearance prices it has to offer to sell inventory left over from the first two quarters of the year.</li> <li>On liquidity, the company says it will have over $2B on tap at the end of the year after it takes into account the common stock offering. (PR)</li> <li>JCP <font color=\"green\">+5.6%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1318042\" data-linked=\"J.C. Penney higher after issuing update\" data-tweet=\"$JCP - J.C. Penney higher after issuing update https://seekingalpha.com/news/1318042-j-c-penney-higher-after-issuing-update?source=tweet\" data-url=\"https://seekingalpha.com/news/1318042-j-c-penney-higher-after-issuing-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1318022\" data-ts=\"1381232103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWGP\" target=\"_blank\">TWGP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1318022-tower-group-takes-goodwill-impairment-charge-boosts-reserves-shares-plunge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tower Group takes goodwill impairment charge, boosts reserves; shares plunge</a></h4><ul><li>Tower Group (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TWGP\" title=\"Tower Group, Inc.\">TWGP</a>)Â <font color=\"red\">plunges 26.5%</font>Â in premarket trade after announcing a $215M goodwill impairment charge for Q2. The company is also boosting its loss reserves by $365M.</li></ul><div class=\"tiny-share-widget\" data-id=\"1318022\" data-linked=\"Tower Group takes goodwill impairment charge, boosts reserves; shares plunge\" data-tweet=\"$TWGP - Tower Group takes goodwill impairment charge, boosts reserves; shares plunge https://seekingalpha.com/news/1318022-tower-group-takes-goodwill-impairment-charge-boosts-reserves-shares-plunge?source=tweet\" data-url=\"https://seekingalpha.com/news/1318022-tower-group-takes-goodwill-impairment-charge-boosts-reserves-shares-plunge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1317792\" data-ts=\"1381222254\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1317792-asian-shares-higher-europe-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Asian shares higher, Europe lower</a></h4><ul>   <li>Asian shares mostly rise as Chinese stocks <font color=\"green\">climb 1.1%</font> on the first day of trading following a week-long national holiday, with retailers and property developers <a href=\"http://www.bloomberg.com/news/2013-10-08/china-s-stock-index-futures-are-little-changed-after-holiday.html\" target=\"_blank\">boosted by higher sales</a> during the period. The Shanghai Composite rose despite a <a href=\"https://seekingalpha.com/currents/post/1317712\" target=\"_blank\">dip</a> in HSBC services PMI data.</li>    <li>\n<a href=\"http://www.marketwatch.com/story/european-stocks-slip-amid-shutdown-chinese-data-2013-10-08\" target=\"_blank\">European shares</a> are mostly lower as the deadlock in Washington continues, although U.S. stock futures are up following losses on Wall Street yesterday.</li>    <li>Japan <font color=\"green\">+0.3%</font>, Hong Kong <font color=\"green\">+0.9%</font>, India <font color=\"green\">+0.6%</font>.</li>    <li>EU Stoxx 50 <font color=\"red\">-0.05%</font>, London <font color=\"red\">-0.3%</font>, Paris <font color=\"red\">-0.3%</font>, Frankfurt flat, Milan <font color=\"green\">+0.2%</font>, Madrid <font color=\"red\">-0.2%</font>.</li>    <li>U.S. stock futures: Dow <font color=\"green\">+0.1%</font>. S&amp;P <font color=\"green\">+0.2%</font>. Nasdaq <font color=\"green\">+0.2%</font>\n</li>    <li>ETFs: <a href=\"https://seekingalpha.com/symbol/efa\" title=\"iShares MSCI EAFE ETF\">EFA</a>, <a href=\"https://seekingalpha.com/symbol/iefa\" title=\"iShares Core MSCI EAFE ETF\">IEFA</a>, <a href=\"https://seekingalpha.com/symbol/vea\" title=\"Vanguard FTSE Developed Markets ETF\">VEA</a>, <a href=\"https://seekingalpha.com/symbol/adrd\" title=\"BLDRS Developed Markets 100 ADR Index ETF\">ADRD</a>, <a href=\"https://seekingalpha.com/symbol/mfla\" title=\"iPath Long Enhanced 2x MSCI EAFE Index ETN\">MFLA</a>, <a href=\"https://seekingalpha.com/symbol/efo\" title=\"ProShares Ultra MSCI EAFE ETF\">EFO</a>, <a href=\"https://seekingalpha.com/symbol/efu\" title=\"ProShares UltraShort MSCI EAFE ETF\">EFU</a>, <a href=\"https://seekingalpha.com/symbol/pdn\" title=\"PowerShares FTSE RAFI Developed Markets ex-U.S. Small-Mid Portfolio ETF\">PDN</a>, <a href=\"https://seekingalpha.com/symbol/piz\" title=\"PowerShares DWA Developed Markets Momentum Portfolio ETF\">PIZ</a>, <a href=\"https://seekingalpha.com/symbol/efz\" title=\"ProShares Short MSCI EAFE ETF\">EFZ</a>, <a href=\"https://seekingalpha.com/symbol/pxf\" title=\"PowerShares FTSE RAFI Developed Markets ex-U.S. Portfolio ETF\">PXF</a>, <a href=\"https://seekingalpha.com/symbol/efg\" title=\"iShares MSCI EAFE Growth ETF\">EFG</a>, <a href=\"https://seekingalpha.com/symbol/efv\" title=\"iShares MSCI EAFE Value ETF\">EFV</a>, <a href=\"https://seekingalpha.com/symbol/dzk\" title=\"Direxion Developed Markets Bull 3X Shares ETF\">DZK</a>, <a href=\"https://seekingalpha.com/symbol/dpk\" title=\"Direxion Developed Markets Bear 3X Shares ETF\">DPK</a>, <a href=\"https://seekingalpha.com/symbol/idlv\" title=\"PowerShares S&amp;P International Developed Low Volatility Portfolio ETF\">IDLV</a>, <a href=\"https://seekingalpha.com/symbol/dth\" title=\"WisdomTree DEFA  Equity Income ETF\">DTH</a>, <a href=\"https://seekingalpha.com/symbol/dwm\" title=\"WisdomTree DEFA  ETF\">DWM</a>, <a href=\"https://seekingalpha.com/symbol/urth\" title=\"iShares MSCI World ETF\">URTH</a>, <a href=\"https://seekingalpha.com/symbol/fdts\" title=\"First Trust Developed Markets ex-US Small Cap AlphaDEX ETF\">FDTS</a>, <a href=\"https://seekingalpha.com/symbol/fxi\" title=\"iShares China Large-Cap ETF\">FXI</a>, <a href=\"https://seekingalpha.com/symbol/gxc\" title=\"SPDR S&amp;P China ETF\">GXC</a>, <a href=\"https://seekingalpha.com/symbol/pgj\" title=\"PowerShares Golden Dragon China Portfolio ETF\">PGJ</a>, <a href=\"https://seekingalpha.com/symbol/yao\" title=\"Guggenheim China All-Cap ETF \">YAO</a>, <a href=\"https://seekingalpha.com/symbol/fchi\" title=\"iShares FTSE China (HK-Listed) Index ETF\">FCHI</a>, <a href=\"https://seekingalpha.com/symbol/pek\" title=\"Market Vectors China ETF \">PEK</a>, <a href=\"https://seekingalpha.com/symbol/caf\" title=\"Morgan Stanley China A Share Fund\">CAF</a>, <a href=\"https://seekingalpha.com/symbol/yxi\" title=\"ProShares Short FTSE China 25 ETF\">YXI</a>, <a href=\"https://seekingalpha.com/symbol/xpp\" title=\"ProShares Ultra FTSE China 25 ETF\">XPP</a>, <a href=\"https://seekingalpha.com/symbol/fxp\" title=\"ProShares UltraShort FTSE China 25 ETF\">FXP</a>, <a href=\"https://seekingalpha.com/symbol/mchi\" title=\"iShares MSCI China ETF\">MCHI</a>, <a href=\"https://seekingalpha.com/symbol/yinn\" title=\"Direxion Daily China Bull 3x Shares ETF\">YINN</a>, <a href=\"https://seekingalpha.com/symbol/yang\" title=\"Direxion Daily China Bear 3x Shares ETF\">YANG</a>, <a href=\"https://seekingalpha.com/symbol/tchi\" title=\"RBS China Trendpilot ETN\">TCHI</a>, <a href=\"https://seekingalpha.com/symbol/chxf\" title=\"WisdomTree China Dividend ex-Financials ETF\">CHXF</a>, <a href=\"https://seekingalpha.com/symbol/kfyp\" title=\"KraneShares CSI China Five Year Plan ETF\">KFYP</a>, <a href=\"https://seekingalpha.com/symbol/hao\" title=\"Guggenheim China Small Cap ETF \">HAO</a>, <a href=\"https://seekingalpha.com/symbol/ecns\" title=\"iShares MSCI China Small-Cap ETF\">ECNS</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1317792\" data-linked=\"Asian shares higher, Europe lower\" data-tweet=\"$EFA $IEFA $VEA - Asian shares higher, Europe lower https://seekingalpha.com/news/1317792-asian-shares-higher-europe-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/1317792-asian-shares-higher-europe-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 AM </div></div></li>","count":40,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}